Evidence map›Paper›PMID 32123974›Full record

ArticlePsychopharmacology2020

Effects of 5-HT

Trevor Humby, Georgia E Smith, Rebecca Small, William Davies, Jenny Carter, Chloe A Bentley, Catharine A Winstanley, Robert D Rogers, Lawrence S Wilkinson

Open access · hybridAbstract read
In one paragraph

Article in Psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Trevor HumbyBehavioral Genetics Group, Schools of Medicine and Psychology, Cardiff University, Cardiff, CF10 3AT, UK. humbyt@cardiff.ac.uk.ORCID http://orcid.org/0000-0002-1840-1799
Georgia E SmithBehavioral Genetics Group, Schools of Medicine and Psychology, Cardiff University, Cardiff, CF10 3AT, UK.
Rebecca SmallBehavioral Genetics Group, Schools of Medicine and Psychology, Cardiff University, Cardiff, CF10 3AT, UK.
William DaviesBehavioral Genetics Group, Schools of Medicine and Psychology, Cardiff University, Cardiff, CF10 3AT, UK.
Jenny CarterBehavioral Genetics Group, Schools of Medicine and Psychology, Cardiff University, Cardiff, CF10 3AT, UK.
Chloe A BentleyBehavioral Genetics Group, Schools of Medicine and Psychology, Cardiff University, Cardiff, CF10 3AT, UK.
Catharine A WinstanleyDepartment of Psychology, University of British Columbia, Vancouver, Canada.
Robert D RogersSchool of Psychology, Bangor University, Bangor, UK.
Lawrence S WilkinsonBehavioral Genetics Group, Schools of Medicine and Psychology, Cardiff University, Cardiff, CF10 3AT, UK. wilkinsonl@cardiff.ac.uk.
Cardiff University · GBBangor University · GBUniversity of British Columbia · CA

Funding

Medical Research Council MR/L010305/1Medical Research Council (UK) MR/L010305/1Wellcome TrustWellcome Trust (GB) 100202/Z/12/Z
6 · The paper itself

Abstract

rationaleProblematic patterns of gambling are characterised by loss of control and persistent gambling often to recover losses. However, little is known about the mechanisms that mediate initial choices to begin gambling and then continue to gamble in the face of losing outcomes.

objectivesThese experiments first assessed gambling and loss-chasing performance under different win/lose probabilities in C57Bl/6 mice, and then investigated the effects of antagonism of 5-HT

resultsAs seen in humans and other species, mice demonstrated the expected patterns of behaviour as the odds for winning were altered increasing gambling and loss-chasing when winning was more likely. SB242084 decreased the likelihood to initially gamble, but had no effects on subsequent gambling choices in the face of repeated losses. In contrast, 8-OH-DPAT had no effects on choosing to gamble in the first place, but once started 8-OH-DPAT increased gambling choices in a dose-sensitive manner. Modafinil effects were different to the serotonergic drugs in both decreasing the propensity to initiate gambling and chase losses.

conclusionsWe present evidence for dissociable effects of systemic drug administration on different aspects of gambling behaviour. These data extend and reinforce the importance of serotonergic mechanisms in mediating discrete components of gambling behaviour. They further demonstrate the ability of modafinil to reduce gambling behaviour. Our work using a novel mouse paradigm may be of utility in modelling the complex psychological and neurobiological underpinnings of gambling problems, including the analysis of genetic and environmental factors.

Indexed as

Reinforcement, Psychology8-Hydroxy-2-(di-n-propylamino)tetralinAnimalsCentral Nervous System StimulantsCognitionGamblingHumansMaleMiceModafinilReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT2CSerotoninSerotonin 5-HT1 Receptor Agonists5-hydroxytryptamine2C receptor, mouse8-Hydroxy-2-(di-n-propylamino)tetralinCentral Nervous System StimulantsModafinilReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT2CSerotoninSerotonin 5-HT1 Receptor Agonists5-HT1AR5-HT2CR8-OH-DPATGamblingLoss-chasingModafinilSB242084Touchscreen

Identifiers

PMID32123974
PMCPMC7239826
OpenAlexW3009053636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.